#United States #New York #Halper Sadeh #RGLS #KRON

Halper Sadeh LLC Initiates Investigations into RGLS, KRON, and SWTX

In a recent announcement, Halper Sadeh LLC, a law firm dedicated to investor rights, is probing into three public companies: Regulus Therapeutics Inc. (RGLS), Kronos Bio, Inc. (KRON), and SpringWorks Therapeutics, Inc. (SWTX). The firm aims to determine whether these companies have violated federal securities laws and/or breached their fiduciary duties to shareholders, particularly in connection with recent proposed sales.

Investigation Details

Each of these investigations stems from proposed transactions involving substantial cash payments to shareholders. Regulus Therapeutics has made headlines with its sale to Novartis AG. The shareholders of Regulus stand to receive $7.00 in cash for every share they hold, along with a contingent value right that could potentially yield another $7.00 per share based upon regulatory approval for their leading product candidate, farabursen. This arrangement has raised eyebrows regarding the company’s responsibilities and the fairness of the deal to shareholders.

Kronos Bio, on the other hand, is on the path to being acquired by Concentra Biosciences, LLC. Under the proposed terms, Kronos shareholders would receive $0.57 in cash for each share, plus a non-tradable contingent value right. The implications of this transaction have prompted Halper Sadeh to assess whether stakeholders are being adequately protected in the deal’s structuring.

In a more lucrative offer, SpringWorks Therapeutics has a proposed sale to Merck KGaA, valued at $47.00 per share in cash. As with the previous transactions, shareholders' rights and potential misconduct are under scrutiny.

Rights and Options for Shareholders

Halper Sadeh LLC is reaching out to shareholders of these firms, urging them to examine their legal rights and options in light of the proposed transactions. As part of their investigation, the firm is looking to secure increased payment, address any lack of transparency in the transactions, and pursue other potential benefits for shareholders. Notably, the firm operates on a contingency basis, meaning shareholders would not incur out-of-pocket legal fees unless the case results in a financial recovery.

The firm encourages any shareholders of RGLS, KRON, or SWTX to connect with their offices for a no-cost consultation to discuss their particular situations. Those interested are encouraged to contact attorneys Daniel Sadeh or Zachary Halper directly by phone or via email.

Halper Sadeh LLC has a history of advocating for investors who have been victims of corporate wrongdoing and securities fraud, and their efforts have led to substantial recoveries for those affected. The firm prides itself on its role in pursuing corporate reforms that benefit shareholders and the broader investing community.

Conclusion

As the investigations proceed, shareholders following these developments should stay vigilant regarding their rights and any changes that may impact their investments. With the backing of experienced legal counsel, stakeholders can better navigate the complexities of these transactions and ensure their interests are adequately represented.

For more information and to initiate a discussion about legal options, shareholders should reach out to Halper Sadeh LLC promptly. This could be a critical moment in their investments regarding the future direction of these companies and their proposed transactions.